Natco Pharma Limited
NATCOPHARM

Natco Pharma Limited

Pharmaceuticals
Share price
882
Market cap
₹15,806 Cr
1Y return
1%

A vertically integrated pharmaceutical company engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas. Natco Pharma operates across three core business segments: finished dosage formulations, active pharmaceutical ingredients, and contract manufacturing services. The company maintains a strong research and development focus to drive innovation and develop specialized therapeutic solutions across oncology, cardiovascular, gastroenterology, and other critical therapeutic domains.

Investors holding Natco Pharma Limited

B
Belgrave
Foreign Investor
2.31%
LIC
LIC
Institution
2.24%
1.01%

Latest move

LICNew position
LIC initiated a new position in Natco Pharma, acquiring 40,09,317 shares, representing a 2.24% stake. The investment is valued at ₹385.54 Cr based on Natco Pharma's share price of ₹961.60.
9 Jul 2026Sign in to read more

Whales made 2 more moves in Natco Pharma Limited

Sign in to see who is buying and selling.

Sign in to find out
Natco Pharma — investor holdings · WhaleWatch